1. Home
  2. DCO vs AGIO Comparison

DCO vs AGIO Comparison

Compare DCO & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$149.50

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.18

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
AGIO
Founded
1849
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
DCO
AGIO
Price
$149.50
$28.18
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$153.60
$38.88
AVG Volume (30 Days)
199.7K
741.6K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$824,730,000.00
$43,011,000.00
Revenue This Year
$7.40
$76.75
Revenue Next Year
$8.59
$170.73
P/E Ratio
$232.22
N/A
Revenue Growth
4.85
N/A
52 Week Low
$71.40
$22.24
52 Week High
$156.32
$46.00

Technical Indicators

Market Signals
Indicator
DCO
AGIO
Relative Strength Index (RSI) 56.87 47.49
Support Level $135.11 $26.75
Resistance Level $156.32 $29.37
Average True Range (ATR) 5.97 1.13
MACD 0.24 0.18
Stochastic Oscillator 65.61 23.05

Price Performance

Historical Comparison
DCO
AGIO

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: